Article summary
The European Commission has confirmed that the proposal to progressively roll out Regulation (EU) 2017/746 (the In Vitro Diagnostic Medical Devices Regulation (IVDR)) due to a delay in its implementation as a result of the coronavirus (COVID-19) pandemic and the shortage of notified body capacity, has been adopted by the European Parliament and the Council of the European Union. Although, overall, the IVDR will apply from 26 May 2022 as scheduled, requirements for higher risk devices in Class D will now apply from May 2025, for lower risk Class C devices from May 2026 and for lower risk Class devices in Class B and A sterile, the requirements will be applicable from May 2027. In addition, the application of certain requirements for devices manufactured and used in the same health institution will be delayed to May 2024.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial